Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci

Details for Australian Patent Application No. 2001261557 (hide)

Owner Amgen Inc.

Inventors Yu, Gang; Theill, Lars Eyde

Agent Shelston IP

Pub. Number AU-B-2001261557

PCT Pub. Number WO01/87977

Priority 60204039 12.05.00 US; 60214591 27.06.00 US

Filing date 14 May 2001

Wipo publication date 26 November 2001

Acceptance publication date 30 June 2005

International Classifications

C07K 014/705 Peptides having more than 20 amino acids

A61P 035/00 Antineoplastic agents

C12N 015/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

C07K 019/00 Hybrid peptides

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

Event Publications

30 June 2005 Application Accepted

  Published as AU-B-2001261557

27 October 2005 Standard Patent Sealed

10 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001261558

2001261556